2025-04-012026-03-312026-03-31false08235635HERTFORDSHIRE HIP & KNEE CARE LIMITED2026-07-15falseiso4217:GBPxbrli:pure082356352025-03-31082356352026-03-31082356352025-04-012026-03-31082356352024-03-31082356352025-03-31082356352024-04-012025-03-3108235635bus:SmallEntities2025-04-012026-03-3108235635bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3108235635bus:FullAccounts2025-04-012026-03-3108235635bus:PrivateLimitedCompanyLtd2025-04-012026-03-3108235635core:WithinOneYear2026-03-3108235635core:AfterOneYear2026-03-3108235635core:WithinOneYear2025-03-3108235635core:AfterOneYear2025-03-3108235635core:ShareCapital2026-03-3108235635core:SharePremium2026-03-3108235635core:RevaluationReserve2026-03-3108235635core:OtherReservesSubtotal2026-03-3108235635core:RetainedEarningsAccumulatedLosses2026-03-3108235635core:ShareCapital2025-03-3108235635core:SharePremium2025-03-3108235635core:RevaluationReserve2025-03-3108235635core:OtherReservesSubtotal2025-03-3108235635core:RetainedEarningsAccumulatedLosses2025-03-3108235635core:LandBuildings2026-03-3108235635core:PlantMachinery2026-03-3108235635core:Vehicles2026-03-3108235635core:FurnitureFittings2026-03-3108235635core:OfficeEquipment2026-03-3108235635core:NetGoodwill2026-03-3108235635core:IntangibleAssetsOtherThanGoodwill2026-03-3108235635core:ListedExchangeTraded2026-03-3108235635core:UnlistedNon-exchangeTraded2026-03-3108235635core:LandBuildings2025-03-3108235635core:PlantMachinery2025-03-3108235635core:Vehicles2025-03-3108235635core:FurnitureFittings2025-03-3108235635core:OfficeEquipment2025-03-3108235635core:NetGoodwill2025-03-3108235635core:IntangibleAssetsOtherThanGoodwill2025-03-3108235635core:ListedExchangeTraded2025-03-3108235635core:UnlistedNon-exchangeTraded2025-03-3108235635core:LandBuildings2025-04-012026-03-3108235635core:PlantMachinery2025-04-012026-03-3108235635core:Vehicles2025-04-012026-03-3108235635core:FurnitureFittings2025-04-012026-03-3108235635core:OfficeEquipment2025-04-012026-03-3108235635core:NetGoodwill2025-04-012026-03-3108235635core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3108235635core:ListedExchangeTraded2025-04-012026-03-3108235635core:UnlistedNon-exchangeTraded2025-04-012026-03-3108235635core:MoreThanFiveYears2025-04-012026-03-3108235635core:Non-currentFinancialInstruments2026-03-3108235635core:Non-currentFinancialInstruments2025-03-3108235635dpl:CostSales2025-04-012026-03-3108235635dpl:DistributionCosts2025-04-012026-03-3108235635core:LandBuildings2025-04-012026-03-3108235635core:PlantMachinery2025-04-012026-03-3108235635core:Vehicles2025-04-012026-03-3108235635core:FurnitureFittings2025-04-012026-03-3108235635core:OfficeEquipment2025-04-012026-03-3108235635dpl:AdministrativeExpenses2025-04-012026-03-3108235635core:NetGoodwill2025-04-012026-03-3108235635core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3108235635dpl:GroupUndertakings2025-04-012026-03-3108235635dpl:ParticipatingInterests2025-04-012026-03-3108235635dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3108235635core:ListedExchangeTraded2025-04-012026-03-3108235635dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3108235635core:UnlistedNon-exchangeTraded2025-04-012026-03-3108235635dpl:CostSales2024-04-012025-03-3108235635dpl:DistributionCosts2024-04-012025-03-3108235635core:LandBuildings2024-04-012025-03-3108235635core:PlantMachinery2024-04-012025-03-3108235635core:Vehicles2024-04-012025-03-3108235635core:FurnitureFittings2024-04-012025-03-3108235635core:OfficeEquipment2024-04-012025-03-3108235635dpl:AdministrativeExpenses2024-04-012025-03-3108235635core:NetGoodwill2024-04-012025-03-3108235635core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108235635dpl:GroupUndertakings2024-04-012025-03-3108235635dpl:ParticipatingInterests2024-04-012025-03-3108235635dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3108235635core:ListedExchangeTraded2024-04-012025-03-3108235635dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3108235635core:UnlistedNon-exchangeTraded2024-04-012025-03-3108235635core:NetGoodwill2026-03-3108235635core:IntangibleAssetsOtherThanGoodwill2026-03-3108235635core:LandBuildings2026-03-3108235635core:PlantMachinery2026-03-3108235635core:Vehicles2026-03-3108235635core:FurnitureFittings2026-03-3108235635core:OfficeEquipment2026-03-3108235635core:AfterOneYear2026-03-3108235635core:WithinOneYear2026-03-3108235635core:ListedExchangeTraded2026-03-3108235635core:UnlistedNon-exchangeTraded2026-03-3108235635core:ShareCapital2026-03-3108235635core:SharePremium2026-03-3108235635core:RevaluationReserve2026-03-3108235635core:OtherReservesSubtotal2026-03-3108235635core:RetainedEarningsAccumulatedLosses2026-03-3108235635core:NetGoodwill2025-03-3108235635core:IntangibleAssetsOtherThanGoodwill2025-03-3108235635core:LandBuildings2025-03-3108235635core:PlantMachinery2025-03-3108235635core:Vehicles2025-03-3108235635core:FurnitureFittings2025-03-3108235635core:OfficeEquipment2025-03-3108235635core:AfterOneYear2025-03-3108235635core:WithinOneYear2025-03-3108235635core:ListedExchangeTraded2025-03-3108235635core:UnlistedNon-exchangeTraded2025-03-3108235635core:ShareCapital2025-03-3108235635core:SharePremium2025-03-3108235635core:RevaluationReserve2025-03-3108235635core:OtherReservesSubtotal2025-03-3108235635core:RetainedEarningsAccumulatedLosses2025-03-3108235635core:NetGoodwill2024-03-3108235635core:IntangibleAssetsOtherThanGoodwill2024-03-3108235635core:LandBuildings2024-03-3108235635core:PlantMachinery2024-03-3108235635core:Vehicles2024-03-3108235635core:FurnitureFittings2024-03-3108235635core:OfficeEquipment2024-03-3108235635core:AfterOneYear2024-03-3108235635core:WithinOneYear2024-03-3108235635core:ListedExchangeTraded2024-03-3108235635core:UnlistedNon-exchangeTraded2024-03-3108235635core:ShareCapital2024-03-3108235635core:SharePremium2024-03-3108235635core:RevaluationReserve2024-03-3108235635core:OtherReservesSubtotal2024-03-3108235635core:RetainedEarningsAccumulatedLosses2024-03-3108235635core:AfterOneYear2025-04-012026-03-3108235635core:WithinOneYear2025-04-012026-03-3108235635core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3108235635core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3108235635core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3108235635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3108235635core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3108235635core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3108235635core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108235635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108235635core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108235635core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3108235635core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3108235635core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3108235635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3108235635core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3108235635core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3108235635core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3108235635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3108235635core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3108235635core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3108235635core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3108235635core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3108235635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3108235635core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3108235635core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3108235635core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3108235635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3108235635core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3108235635bus:Director12025-04-012026-03-3108235635bus:Director22025-04-012026-03-31

HERTFORDSHIRE HIP & KNEE CARE LIMITED

Registered Number
08235635
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

HERTFORDSHIRE HIP & KNEE CARE LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

DE ROECK, Nicholas John
JOY, Kathryn Elizabeth

Registered Address

1st Floor, Buckley House 31a The Hundred
Romsey
SO51 8GD

Registered Number

08235635 (England and Wales)
HERTFORDSHIRE HIP & KNEE CARE LIMITED
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets4717230
717230
Current assets
Debtors517,4398,213
Current asset investments671,43458,634
Cash at bank and on hand31,38048,769
120,253115,616
Creditors amounts falling due within one year7(45,950)(48,975)
Net current assets (liabilities)74,30366,641
Total assets less current liabilities75,02066,871
Net assets75,02066,871
Capital and reserves
Called up share capital150150
Profit and loss account74,87066,721
Shareholders' funds75,02066,871
The financial statements were approved and authorised for issue by the Board of Directors on 15 July 2026, and are signed on its behalf by:
DE ROECK, Nicholas John
Director
Registered Company No. 08235635
HERTFORDSHIRE HIP & KNEE CARE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Office Equipment50
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20262025
Average number of employees during the year22
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 2527,30027,300
At 31 March 2627,30027,300
Amortisation and impairment
At 01 April 2527,30027,300
At 31 March 2627,30027,300
Net book value
At 31 March 26--
At 31 March 25--
4.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 April 255,0795,079
Additions849849
At 31 March 265,9285,928
Depreciation and impairment
At 01 April 254,8494,849
Charge for year362362
At 31 March 265,2115,211
Net book value
At 31 March 26717717
At 31 March 25230230
5.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables9,128-
Prepayments and accrued income8,3118,213
Total17,4398,213
6.Current asset investments
7.Creditors: amounts due within one year

2026

2025

££
Taxation and social security41,83345,116
Other creditors995859
Accrued liabilities and deferred income3,1223,000
Total45,95048,975